Health & Support
    18 mins ago

    Who Is Not A Good Candidate For Ketamine Therapy?

    Nowadays, ketamine therapy has gained significant popularity for the treatment of mental health issues like…
    Social illness
    37 mins ago

    Doctors working in paediatrics and anaesthetics at higher risk of suicidality, according to Australian survey

    The recent COVID-19 pandemic exposed the stark reality of some of the challenges faced by…
    Pharma News
    46 mins ago

    CST-2140 by CuraSen Therapeutics for Orthostatic Hypotension: Likelihood of Approval

    CST-2140 is under clinical development by CuraSen Therapeutics and currently in Phase I for Orthostatic…
    Pharma News
    1 hour ago

    Ulotaront hydrochloride by Sumitomo Pharma America for Schizophrenia: Likelihood of Approval

    Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III…
    Pharma News
    2 hours ago

    Ulotaront hydrochloride by Sumitomo Pharma America for Generalized Anxiety Disorder (GAD): Likelihood of Approval

    Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III…
    Pharma News
    2 hours ago

    Denosumab biosimilar by Sandoz Group for Bone Metastasis: Likelihood of Approval

    Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Bone…
    Pharma News
    3 hours ago

    Denosumab biosimilar by Sandoz Group for Post Menopausal Osteoporosis: Likelihood of Approval

    Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Post…
    Pharma News
    3 hours ago

    Denosumab biosimilar by Sandoz Group for Humoral Hypercalcemia of Malignancy: Likelihood of Approval

    Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Humoral…
    Pharma News
    4 hours ago

    Denosumab biosimilar by Sandoz Group for Giant Cell Tumor Of Bone: Likelihood of Approval

    Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Giant…
    Pharma News
    5 hours ago

    Denosumab biosimilar by Celltrion for Osteoporosis: Likelihood of Approval

    Denosumab biosimilar is under clinical development by Celltrion and currently in Phase I for Osteoporosis.…
      Health & Support
      18 mins ago

      Who Is Not A Good Candidate For Ketamine Therapy?

      Nowadays, ketamine therapy has gained significant popularity for the treatment of mental health issues like anxiety, depression, or post-traumatic stress…
      Social illness
      37 mins ago

      Doctors working in paediatrics and anaesthetics at higher risk of suicidality, according to Australian survey

      The recent COVID-19 pandemic exposed the stark reality of some of the challenges faced by individuals working within healthcare, and…
      Pharma News
      46 mins ago

      CST-2140 by CuraSen Therapeutics for Orthostatic Hypotension: Likelihood of Approval

      CST-2140 is under clinical development by CuraSen Therapeutics and currently in Phase I for Orthostatic Hypotension. Source link #CST2140 #CuraSen…
      Pharma News
      1 hour ago

      Ulotaront hydrochloride by Sumitomo Pharma America for Schizophrenia: Likelihood of Approval

      Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III for Schizophrenia. Source link #Ulotaront…